CD9 and cancer: The overall data indicate that the CD9-RFP is the best recombinant protein to be expressed in HEK293 cells, as it is massively sorted onto EVs and correctly transferred to recipient cells where the destiny of an RFP tag remains sensitive to cell specific enzymatic activity, paving thus the way to the EVs-based delivery and selective release of therapeutic proteins in cancer cells.